$4.85
▼ -0.2% Today
as of Sep 4, 16:56 ET
Last 30 days
Recent Press Releases & News
Wave Life Sciences to Present at Cantor 2026 Global Healthcare Conference
Wave Life Sciences: A $1 Billion RNA-Medicine Bargain Ripe for Pharma Takeover
Wave Life Sciences Completes Redomiciliation to Delaware
Overview
52-week range
$4.65
$22
1% of range
Avg surprise (last 2)
-7.2%
Avg reaction (last 1)
+0.8%
100% positive
Latest IV / EM
76%
EM ±11.8% · $5 · Sep 18
Earnings trends
EPS — actual vs estimate
Actual Estimate
Revenue vs Net Income
Revenue Net income
Earnings history
| Date | Period | Actual EPS | Est | Surprise | YoY %Δ | Day react | Source |
|---|---|---|---|---|---|---|---|
| Tue Jun 30, 2026 | Jun 2026 | $-0.34 | — | — | — | — | financials |
| Tue Mar 31, 2026 | Mar 2026 | $-0.13 | — | — | — | — | financials |
| Tue Sep 30, 2025 | Sep 2025 | $-0.32 | — | — | — | — | financials |
| Wed Jul 30, 2025 | Jun/2025 | $-0.31 | $-0.29 | -6.9% | — | — | earnings |
| Thu May 8, 2025 | Mar/2025 | $-0.29 | $-0.27 | -7.4% | — | +0.8% | earnings |
| Mon Sep 30, 2024 | Sep 2024 | $-0.47 | — | — | — | — | financials |
| Sun Jun 30, 2024 | Jun 2024 | $-0.25 | — | — | — | — | financials |
| Sun Mar 31, 2024 | Mar 2024 | $-0.24 | — | — | — | — | financials |
| Sat Sep 30, 2023 | Sep 2023 | $0.07 | — | — | — | — | financials |
| Fri Jun 30, 2023 | Jun 2023 | $-0.20 | — | — | — | — | financials |
| Fri Mar 31, 2023 | Mar 2023 | $-0.27 | — | — | — | — | financials |
Financials
Income statement (quarterly)
| Metric | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $2M | $38M | — | — | $9M | $9M | — | — |
| Cost of revenue | — | — | — | — | — | — | — | — |
| Gross profit | — | — | — | — | — | — | — | — |
| Operating income | $-74M | $-31M | — | $-56M | $-53M | $-50M | — | $-64M |
| Net income | $-69M | $-26M | — | $-54M | $-50M | $-47M | — | $-62M |
| EPS (diluted) | $-0.34 | $-0.13 | — | $-0.32 | $-0.31 | $-0.29 | — | $-0.47 |
Balance sheet (quarterly)
| Metric | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | $368M | $545M | $602M | $196M | $208M | $243M | $302M | $311M |
| Inventory | — | — | — | — | — | — | — | — |
| Total current assets | $508M | $561M | $615M | $215M | $224M | $258M | $320M | $325M |
| Total assets | $558M | $584M | $638M | $241M | $252M | $288M | $352M | $359M |
| Long-term debt | — | — | — | — | — | — | — | — |
| Total liabilities | $105M | $72M | $112M | $109M | $105M | $109M | $135M | $209M |
| Total equity | $454M | $512M | $518M | $125M | $139M | $172M | $210M | $142M |